Atrandi Biosciences
Vilnius · Founded 2016
About Atrandi Biosciences
Atrandi Biosciences, founded in 2016, is a pioneering life sciences tool company transforming single-cell analysis with its patented Semi-Permeable Capsule (SPC) technology. This next-generation technology isolates tens of thousands of single cells within discrete, permeable compartments, allowing bulk reactions to proceed as usual while preserving single-cell resolution. SPCs have already unlocked previously inaccessible applications, such as high-throughput microbial and eukaryotic genomics, and are poised to enable true single-cell multiomics. Headquartered in Vilnius, Lithuania, Atrandi’s name, meaning “you discover” in Lithuanian, embodies the company’s mission to empower scientists to uncover the unknown and make groundbreaking discoveries.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $31.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2025)
- Website: https://www.atrandi.com
- Phone: +37061978075
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/atrandi-biosciences-40367 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.